Loading clinical trials...
Loading clinical trials...
Open-label, Randomized Trial of the Safety and Efficacy of Doxycycline and Rivaroxaban Therapy Versus National Standard Therapy in Ambulatory Patients With Mild Symptomatic COVID-19
Conditions
Interventions
Doxycycline Tablets
Rivaroxaban 15Mg Tab
+1 more
Locations
1
Cameroon
Yaounde Central Hospital
Yaoundé, Centre Region, Cameroon
Start Date
October 5, 2020
Primary Completion Date
May 30, 2021
Completion Date
September 5, 2021
Last Updated
January 20, 2021
NCT06082518
NCT07221162
NCT06631287
NCT06679140
NCT06417762
NCT03830320
Charles Kouanfack, MD, PhD
CONTACT
Lead Sponsor
Yaounde Central Hospital
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions